why choose us

First received: December 13, 2022

Clinical Trial: CARv3-TEAM-E T Cells in Glioblastoma

Study Status: Completed

Recruit Status: RECRUITING

Condition: Glioblastoma

Study Type: INTERVENTIONAL


Official Title: INCIPIENT: INtraventricular CARv3-TEAM-E T Cells for PatIENTs With GBM

Brief Summary: The goal of this research study is to determine the best dose of CARv3-TEAM-E T Cells for treating participants with glioblastoma.The name of the treatment intervention used in this research study is:-CARv3-TEAM-E T Cells (or Autologous T lymphocytes).

Read more